172 related articles for article (PubMed ID: 37443196)
21. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
Patil P; Cieslak A; Bernhart SH; Toprak UH; Wagener R; López C; Wiehle L; Bens S; Altmüller J; Franitza M; Scholz I; Jayne S; Ahearne MJ; Scheffold A; Jebaraj BMC; Schneider C; Costa D; Braun T; Schrader A; Campo E; Dyer MJS; Nürnberg P; Dürig J; Johansson P; Böttcher S; Schlesner M; Herling M; Stilgenbauer S; Macintyre E; Siebert R
Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
[TBL] [Abstract][Full Text] [Related]
22. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
23. [Chronic T-lymphocytic leukemia].
Ishida Y; Kuriya S
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):106-9. PubMed ID: 9851096
[No Abstract] [Full Text] [Related]
24. CLL variants and T-cell-related issues.
Catovsky D
Hematol Cell Ther; 2000 Jun; 42(1):15-9. PubMed ID: 11036945
[No Abstract] [Full Text] [Related]
25. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.
Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G
Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666
[TBL] [Abstract][Full Text] [Related]
26. Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia.
Smith VM; Lomas O; Constantine D; Palmer L; Schuh AH; Bruce D; Gonchar O; Macip S; Jayne S; Dyer MJS; Eyre TA
Blood Adv; 2020 Feb; 4(3):525-529. PubMed ID: 32040552
[TBL] [Abstract][Full Text] [Related]
27. Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia.
Matutes E; Catovsky D
Blood; 1996 Apr; 87(8):3520-1. PubMed ID: 8605373
[No Abstract] [Full Text] [Related]
28. Alternative origin of p13MTCP1-encoding transcripts in mature T-cell proliferations with t(X;14) translocations.
Gritti C; Choukroun V; Soulier J; Madani A; Dastot H; Leblond V; Radford-Weiss I; Valensi F; Varet B; Sigaux F; Stern MH
Oncogene; 1997 Sep; 15(11):1329-35. PubMed ID: 9315101
[TBL] [Abstract][Full Text] [Related]
29. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.
Madani A; Choukroun V; Soulier J; Cacheux V; Claisse JF; Valensi F; Daliphard S; Cazin B; Levy V; Leblond V; Daniel MT; Sigaux F; Stern MH
Blood; 1996 Mar; 87(5):1923-7. PubMed ID: 8634440
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database.
Wasifuddin M; Ilerhunmwuwa NP; Becerra H; Wang JC
Leuk Lymphoma; 2023 Dec; 64(12):2051-2053. PubMed ID: 37531079
[No Abstract] [Full Text] [Related]
31. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
32. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of Novel
Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
[No Abstract] [Full Text] [Related]
34. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
[No Abstract] [Full Text] [Related]
35. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent BAT-25 and BAT-26 analysis of T cell prolymphocytic leukaemia.
Bradshaw PS; Hamoudi R; Min T; Catovsky D; Houlston RS; Yuille MR
Leukemia; 1999 Dec; 13(12):2104-6. PubMed ID: 10602436
[TBL] [Abstract][Full Text] [Related]
37. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
[TBL] [Abstract][Full Text] [Related]
38. Proto-oncogene TCL1: more than just a coactivator for Akt.
Noguchi M; Ropars V; Roumestand C; Suizu F
FASEB J; 2007 Aug; 21(10):2273-84. PubMed ID: 17360849
[TBL] [Abstract][Full Text] [Related]
39. T-cell prolymphocytic leukemia presenting as ascites.
Hermans SJF; Sandberg Y
Blood; 2019 Jul; 134(4):411. PubMed ID: 31345928
[No Abstract] [Full Text] [Related]
40. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
Gallipoli P; Clark A; Leach M
Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
